Kagocel and Sputnik V gain the trust of the medical community

Updated on March 3, 2021

In the battle against the raging pandemic, various vaccines were developed. However, the immunization process is pretty slow around the world. For now, Izrael is the only country that has vaccinated around half of its population. 

The US and Europe are still struggling to proceed with the vaccination process. Some common problems are lack of vaccines, logistics problems, and storing issues. Russia introduced two solutions for fighting the pandemic. These are the Sputnik V vaccine and Kagocel, a medication that contains interferon inducers. 

Quickly after releasing in the famous science magazine Lancet, the article dedicated to Sputnik V gained tremendous popularity. It has become the most debated article in the decade. The Russian President himself confirms the vaccine’s credibility and this article as a reliable source of information. The WHO also approved the report and the information contained. 

According to this high-profile article, the Russian vaccine offers the highest level of protection of 91.6%. It was the first vaccine developed as an answer to the COVID-19 pandemic. Even though credible sources approved the vaccine, EU leaders approach this matter with resistance. 

Even if the Sputnik vaccine is highly efficient, it can’t offer 100% protection. Although the vaccine promises a lot when it comes to returning to normal, things aren’t that straightforward. New strains of the virus continue to emerge, and various countries reported this already. The British strain proved highly infectious, but scientists discovered a new strain that will likely be counteracted with the vaccine. The South African strain is also a subject of discussion, opening a possibility to create effective vaccines against different strains. 

Knowing the other strains might appear in the future, experts are concerned whether the vaccines will work for all strains. The vaccine isn’t the only solution for the pandemic. Kagocel is an existing medicine that contains interferon inducers, used to fight cold and flu. The Russian Ministry of Health widely recommends Kagocel.

The WHO also recognized the current need for this type of medication. The development of immunomodulators is one of the objectives of the Global Strategy to Combat influenza 2019-2030 and a Bold initiative at the SARS. Despite this, the US and EU are still hesitant about Russian vaccines and drugs. Currently, there aren’t many medications that use interferon inducers on the market. They were developed 50 years ago in Russia, with the purpose to protect people in mass collectives. However, the western world doesn’t have this type of medication available. The interferon inducers are a powerful medication that should be included in the battle against this pandemic. 

The current vaccination rate in both US and Europe isn’t enough to reduce the impact of the virus. The problem with lack of vaccines, transportation, and storage, won’t slow down the pandemic. Besides, authorities need to look for alternative ways to stop the spread other than a vaccine.

The Editorial Team at Healthcare Business Today is made up of skilled healthcare writers and experts, led by our managing editor, Daniel Casciato, who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We offer readers access to fresh health, medicine, science, and technology developments and the latest in patient news, emphasizing how these developments affect our lives.